Functional Characterization Service

We first review the probe design, intended biological target, and downstream assay goal to establish a tailored functional validation plan.

• Review the probe type, such as membrane potential probe, ROS/redox probe, ion probe, pH probe, metabolite probe, mitophagy probe, fusion/fission probe, MitoTimer reporter, or custom mitochondrial fluorescent probe.
• Define the intended functional readout, such as fluorescence turn-on, ratiometric response, red/green conversion, mitochondrial/cytosolic redistribution, puncta formation, morphology change, or reporter activation.
• Clarify the target model, including live cells, fixed cells, organoids, tissue sections, isolated mitochondria, reporter cell lines, or high-throughput screening plates.
• Select appropriate positive controls, negative controls, rescue controls, pathway modulators, and orthogonal validation methods.
• Identify possible risks, including nonspecific staining, mitochondrial membrane potential dependence, lysosomal trapping, pH interference, autofluorescence, cytotoxicity, weak response, or poor reproducibility.

Before cell-based validation, we evaluate whether the probe responds correctly to the intended target under controlled conditions.

• Test response to the target analyte or trigger, such as H₂O₂, O₂•⁻, GSH, Ca²⁺, Mg²⁺, pH shift, NADH, ATP/ADP, enzyme activation, or mitochondrial stress-related chemical conditions.
• Measure response kinetics, endpoint stability, linear response range, dynamic range, and detection limit when applicable.
• Evaluate selectivity against related species, such as ROS/RNS/RSS, metal ions, thiols, biological cofactors, amino acids, proteins, and buffer components.
• Assess whether probe response is reversible, irreversible, enzyme-triggered, concentration-dependent, or environmentally sensitive.
• Compare probe behavior in buffer, culture medium, serum-containing medium, and other assay-relevant environments.
• Recommend target concentration ranges and working conditions for biological testing.

A functional mitochondrial probe must enter cells efficiently, produce sufficient signal, and avoid excessive perturbation of cellular physiology.

• Optimize probe loading concentration, incubation time, washing conditions, and recovery time.
• Evaluate cell permeability and intracellular retention across selected cell types.
• Assess whether the probe shows nonspecific accumulation in cytosol, lysosomes, nuclei, plasma membrane, or extracellular matrix.
• Test cytotoxicity under intended staining and imaging conditions.
• Evaluate phototoxicity risk during live-cell or time-lapse imaging.
• Compare probe performance across adherent cells, suspension cells, primary cells, reporter cells, or disease model cells when required.

For mitochondria-targeted probes, localization validation is a key step before interpreting biological signal.

• Perform co-localization imaging with mitochondrial markers.
• Calculate mitochondrial co-localization coefficients or mitochondrial/cytosolic signal ratios.
• Evaluate whether localization depends strongly on mitochondrial membrane potential.
• Test probe retention under mitochondrial depolarization, oxidative stress, metabolic inhibition, or fixation conditions.
• Check possible overlap with lysosomes, endoplasmic reticulum, nuclei, lipid droplets, or plasma membrane.
• Optimize probe structure or assay conditions when localization is unstable or nonspecific.

We validate whether the probe responds correctly in biologically relevant perturbation models.

• Test probe response under positive and negative biological conditions.
• Use mitochondrial uncouplers, respiratory chain inhibitors, ROS inducers, antioxidants, ionophores, metabolic inhibitors, mitophagy inducers, lysosomal inhibitors, apoptosis inducers, or pathway-specific modulators.
• Compare probe signal with orthogonal mitochondrial readouts, such as membrane potential, ROS, ATP/ADP, NADH/NAD⁺, Ca²⁺, pH, apoptosis, cell viability, oxygen consumption, or mitochondrial morphology.
• Establish time-course and dose-response relationships.
• Confirm whether signal change is target-related rather than caused by nonspecific toxicity, cell death, autofluorescence, or probe redistribution.
• Validate probe performance in application-specific models, such as cancer cells, cardiomyocytes, neurons, immune cells, organoids, or drug-treated cells.

Functional characterization also includes converting probe response into a reproducible quantitative assay.

• Define quantitative metrics such as fluorescence intensity, fluorescence ratio, ΔF/F₀, red/green ratio, mitochondrial/cytosolic ratio, puncta count, co-localization index, morphology score, or response area under curve.
• Optimize imaging settings, exposure time, laser intensity, plate format, seeding density, staining protocol, and acquisition timing.
• Establish signal window, assay robustness, intra-plate variation, inter-day reproducibility, and replicate strategy.
• Develop analysis workflows for microscopy, confocal imaging, flow cytometry, fluorescence plate readers, or high-content imaging.
• Support segmentation and image-analysis strategy for mitochondrial networks, puncta, organelle overlap, or cell-level response profiling.
• Prepare assay recommendations for downstream high-content screening or mitochondrial functional profiling.

Many mitochondrial assays require multiple probes or reporters to be used together, so we evaluate whether the functional probe is compatible with other readouts.

• Test compatibility with mitochondrial membrane potential probes, ROS probes, Ca²⁺ probes, pH probes, lysosome markers, nuclear stains, apoptosis dyes, and cell viability indicators.
• Evaluate spectral overlap, channel bleed-through, probe interference, and sequential staining feasibility.
• Assess whether one probe alters the signal or biology of another probe.
• Optimize multicolor imaging order, staining concentration, imaging channels, and acquisition sequence.
• Support assay panels that combine probe response with mitochondrial morphology, ATP/ADP, NADH/NAD⁺, mitophagy, apoptosis, or cell viability readouts.

After validation, we provide a structured report to support downstream decision-making and assay development.

• Summarize functional response data and selectivity results.
• Document cell loading, mitochondrial localization, cytotoxicity, and biological compatibility results.
• Report positive/negative control response, dose-response behavior, and time-course data.
• Provide quantitative readout recommendations and imaging or plate-reader parameter suggestions.
• Summarize assay limitations, troubleshooting notes, and recommendations for high-content screening, biological validation, or mitochondrial functional profiling.